EU/3/10/756

Table of contents

About

On 27 July 2010, orphan designation (EU/3/10/756) was granted by the European Commission to Altacor Ltd, United Kingdom, for tranilast for the prevention of scarring post glaucoma filtration surgery.

Key facts

Active substance
Tranilast
Disease / condition
Prevention of scarring post glaucoma filtration surgery
Date of decision
27/07/2010
Outcome
Positive
Orphan decision number
EU/3/10/756

Sponsor's contact details

Altacor Ltd
St John's Innovation Centre
Cowley Road
Cambridge
Cambridgeshire CB4 0WS
United Kingdom
Telephone: + 44 1223 421 411
Telefax: + 44 1223 420 844
E-mail: info@altacor-pharma.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • International Glaucoma Association
    Woodcote House
    15 Highpoint Business Village
    Henwood
    Ashford TN24 8DH
    United Kingdom
    Telephone: +44 1233 64 81 70
    Telefax: +44 1233 64 81 79
    E-mail: info@iga.org.uk
  • Initiative Glaukom-Kinder
    Selbsthilfe-Initiative Glaukom-Kinder
    Clueser Strasse 32
    28857 Syke
    Germany
    E-mail: info@glaukom-kinder.de

How useful was this page?

Add your rating